BioStock: BiBBInstruments remains optimistic despite temporary pause in studies

BiBBInstruments recently published the report for the first quarter of 2021, in which the main event was the start of the pilot study with the biopsy instrument EndoDrill Model X in bladder cancer. However, production problems at a supplier have led to a temporary pause in patient recruitment, but the company remains optimistic as they expect the studies to resume in the second quarter. In addition, the company sees the long-term potential and benefits of the electric endoscopic biopsy instrument.

Read the full article at biostock.se:

https://www.biostock.se/en/bibbinstruments-remains-optimistic-despite-temporary-pause-in-studies/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se